Trial intelligence / Profile preview

S-1 and Oxaliplatin in Elderly Advanced Gastric Cancer

NCT04694404Phase 2Unknown

Start
May 2016
Primary completion
Dec 2021
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of tegafur, oxaliplatin in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma. Status: unknown.

02

Drugs

tegafuroxaliplatin
03

Conditions

gastric adenocarcinomagastroesophageal junction adenocarcinoma

Beyond the preview

Go deeper on NCT04694404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04694404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call